A four-gene expression signature for prostate cancer cells consisting of UAP1, PDLIM5, IMPDH2, and HSPD1

UroToday International Journal

Volumn 2, Issue 4, 2009, Pages

  Guyon, Isabelle ^a   Fritsche, Herbert A ^b   Choppa, Paul ^c   Yang, Li Ying ^b   Barnhill, Stephen D ^a  

^a Health Discovery Corporation Inc   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c Clarient Inc   (United States)

Author keywords

DNA microarray; Gene signature; HSPD1; IMPDH2; PDLIM5; Prostate cancer detection; RT PCR assay; Support vector machine; UAP1

Indexed keywords

EID: 70249098912     PISSN: None     EISSN: 19394810     Source Type: Journal    
DOI: 10.3834/uij.1944-5784.2009.08.06     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics 2008. CA Cancer J Clin. 2008;58(2):71-96.
2. Brooks JD. Microarray analysis in prostate cancer research. Curr Opin Urol. 2002;12(5):395-399.
3. Calvo A, Gonzalez-Moreno O, Yoon CY, et al. Prostate cancer and the genomic revolution: Advances using microarray analyses. Mutat Res. 2005;576(1-2):66-79.
4. Elek J, Park KH, Narayanan R. Microarray-based expression profiling in prostate tumors. In Vivo. 2000;14(1):173-182.
5. Saramaki OR, Porkka KP, Vessella RL, Visakorpi T. Genetic aberrations in prostate cancer by microarray analysis. Int J Cancer. 2006;119(6):1322-1329.
6. Xu J, Stolk JA, Zhang X, et al. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res. 2000;60(6):1677-1682.
7. Boser B, Guyon I, Vapnik V. A training algorithm for optimal margin classifiers. Proceedings of the Fifth Annual Workshop on Computational Learning Theory. New York, NY: Association for Computer Machinery; 1992; 144-152.
8. Guyon I, Weston J, Barnhill S, Vapnik V. Gene selection for cancer classification using support vector machines. Mach Learn. 2002;46(1):389-422.
9. Stamey TA, Warrington JA, Caldwell MC, et al. Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. J Urol. 2001;166(6):2171-2177.
10. Rhodes DR, Yu J, Shanker K, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004;6(1):1-6.
11. Singh D, Febbo P, Ross K, et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell. 2002;1(2):203-209.
12. Febbo P, Sellers W. Use of expression analysis to predict outcome after radical prostatectomy. J Urol. 2003;170(6 Pt 2): S11-S20.
13. LaTulippe E, Satagopan J, Smith A, et al. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res. 2002;62(15):4499-4506.
14. Welsh JB, Sapinoso LM, Su AI, et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 2001;61(16):5974-5978.
15. Guyon I, Gunn S, Nikravesh M, Zadeh LA, eds. Feature Extraction Foundations and Applications. Berlin, Germany: Springer-Verlag; 2006.
16. Agresti A, Coull B. Approximate is better than 'exact' for interval estimated binomial proportions. Am Statistician. 1998;52:119-126.
17. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: Chichester Wiley; 2000.
18. DePrimo SE, Diehn M, Nelson JB, et al. Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol. 2002; 3(7): RESEARCH0032.
19. Luo JH, Yu YP, Cieply K, et al. Gene expression analysis of prostate cancers. Mol Carcinog. 2002;33(1):25-35.
20. Diekman AB, Olson G, Goldberg E. Expression of the human antigen SPAG2 in the testis and localization to the outer dense fibers in spermatozoa. Mol Reprod Dev. 1998;50(3):284-293.
21. Febbo PG, Sellers WR. Use of expression analysis to predict outcome after radical prostatectomy. J Urol. 2003;170(6 Pt 2):S11-S20.
22. Henshall SM, Afar DE, Hiller J, et al. Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse. Cancer Res. 2003;63(14):4196-4203.
23. Grusch M, Rosenberger G, Fuhrmann G, et al. Benzamide riboside induces apoptosis independent of Cdc25A expression in human ovarian carcinoma N.1 cells. Cell Death Differ. 1999;6(8):736-744.
24. Sarto C, Binz P-A, Mocarellli P. Heat shock proteins in human cancer. Electrophoresis. 2000;21:1218-1226.